Real-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis

INTRODUCTION: Controlled clinical studies have shown that the efficacy of tocilizumab (TCZ) monotherapy is superior to that of tumor necrosis factor inhibitor (TNFi) monotherapy and comparable to that of TCZ plus methotrexate (MTX) for the treatment of rheumatoid arthritis (RA). This study compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrold, Leslie R., Reed, George W., Best, Jennie, Zlotnick, Steve, Kremer, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251839/
https://www.ncbi.nlm.nih.gov/pubmed/30293218
http://dx.doi.org/10.1007/s40744-018-0127-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251839/
https://www.ncbi.nlm.nih.gov/pubmed/30293218
http://dx.doi.org/10.1007/s40744-018-0127-1

Ejemplares similares